Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil

MLA

Márcia Silveira Graudenz, et al. “Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil.” Journal of Global Oncology, Dec. 2019, pp. 1–8. EBSCOhost, https://doi.org/10.1200/jgo.18.00176.

APA

Márcia Silveira Graudenz, Alvaro Henrique Ingles Garces, Andreia Cristina de Melo, Pedro Duarte Abreu, Carlos Jose C Andrade, Mariana R Monteiro, Ana Paula Stramosk, & Rafael C Coelho. (2019). Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil. Journal of Global Oncology, 1–8. https://doi.org/10.1200/jgo.18.00176

Chicago

Márcia Silveira Graudenz, Alvaro Henrique Ingles Garces, Andreia Cristina de Melo, Pedro Duarte Abreu, Carlos Jose C Andrade, Mariana R Monteiro, Ana Paula Stramosk, and Rafael C Coelho. 2019. “Cisplatin, Fluorouracil in Bolus Injection, and Leucovorin in First-Line Therapy for Advanced Gastric Cancer as an Alternative to Protocols With Infusional Fluorouracil.” Journal of Global Oncology, December, 1–8. doi:10.1200/jgo.18.00176.